Pfizer/BioNTech’s COVID-19 Vaccine Formulation Tweaked to Improve Stability – ToysMatrix

SciCheck Digest
With the release of its pediatric COVID-19 vaccine, Pfizer switched the buffer used in its formulation to increase the stability of the product, allowing it to remain at refrigerator temperatures for longer. The Food and Drug Administration…

Click here to view the original article.